Clinical Trial

Terns Announces Pricing of Upsized $650 Million Public Offering

FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…

2 weeks ago

Terns Announces Pricing of Upsized $650 Million Public Offering

FOSTER CITY, Calif., Dec. 09, 2025 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage…

2 weeks ago

Over 20 Studies of InnoCare’s Orelabrutinib Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

BEIJING, Dec. 09, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

2 weeks ago

Over 20 Studies of InnoCare’s Orelabrutinib Presented at the 67th Annual Meeting of the American Society of Hematology (ASH)

BEIJING, Dec. 09, 2025 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the…

2 weeks ago

Onco-Innovations Chairs Colorectal Cancer Canada Precision Oncology Forum Generating Roadmaps for the Next Era of Cancer Care

VANCOUVER, BC / ACCESS Newswire / December 9, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(Frankfurt:W1H, WKN: A3EKSZ)(OTCQB:ONNVF) ("Onco" or the "Company")…

2 weeks ago

Campo Indictment Exposes DEA Rotted From Within – While Medical Cannabis Research and Patients Wait Seven Years

A Federal Indictment That Reads Like a Narco-State ThrillerDEA corruption reaches new levels with the Campo indictment, even as the…

2 weeks ago

Qualia Life Sciences, Award-Winning Supplement Brand, Celebrates Its 10th Year Anniversary

With Human Studies On Every Formula, Qualia's Industry-Leading Research Standards Are Fueling Innovation and Rapid GrowthCARLSBAD, Calif., Dec. 9, 2025…

2 weeks ago

Sibel Health Awarded a $500,000 Drug Development Tools Research Grant by the FDA for a Novel AI-Enabled Wearable Sensor for Scratch Monitoring

CHICAGO, Dec. 9, 2025 /PRNewswire/ -- Sibel Health, a leader in wearable biosensing and digital health, today announced that it…

2 weeks ago

Ginkgo Bioworks partners on Deep Origin-led team to develop new tools for predicting drug safety

BOSTON, Dec. 9, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced its partnership with Deep Origin on a 4.5-year project…

2 weeks ago

Aptevo Therapeutics Highlights Compelling Safety and Strong Remission Rates for Mipletamig in Frontline AML at ASH 2025

100% of patients in Cohorts 1-3 remain free of cytokine release syndromeCRIS-7-derived CD3 design underpins a controlled T-cell response, supporting…

2 weeks ago